netFormulary
 Report : A-Z HCD items in Formulary 25/02/2018 21:16:46
[Back]
 
Section Status HCD Name
13.05.03 Formulary Cancer Drugs Fund Adalimumab Humira
11.08.02 Formulary Cancer Drugs Fund Aflibercept Eylea
02.12 Formulary Cancer Drugs Fund Alirocumab Praluent
05.03.03.02 Non Formulary Cancer Drugs Fund Boceprevir Victrelis
05.03.01 Formulary Cancer Drugs Fund Cobicistat Tybost
10.03.01 Formulary Cancer Drugs Fund Collagenase Xiapex
05.03.03.02 Formulary Cancer Drugs Fund Daclatasvir Daklinza
05.03.03.02 Formulary Cancer Drugs Fund Dasabuvir Exviera
09.01.03 Formulary Cancer Drugs Fund Deferasirox Exjade
09.01.03 Formulary Cancer Drugs Fund Deferiprone Ferriprox
09.01.03 Formulary Cancer Drugs Fund Desferrioxamine Mesilate 
08.01 Formulary Cancer Drugs Fund Dexrazoxane Savene
05.03.03.02 Formulary Cancer Drugs Fund Elbasvir/Grazoprevir Zepatier 50mg/100mg
09.01.04 Formulary Cancer Drugs Fund Eltrombopag Revolade
13.05.03 Formulary Cancer Drugs Fund Etanercept Enbrel
02.12 Formulary Cancer Drugs Fund Evolocumab Repatha
13.05.03 Formulary Cancer Drugs Fund Infliximab Remicade
05.03.03.02 Formulary Cancer Drugs Fund Ledipasvir/Sofosbuvir Harvoni 90mg/400mg
05.03.03.02 Formulary Cancer Drugs Fund Ombitasvir/Paritaprevir/Ritonavir Viekirax 12.5mg/75mg/50mg
11.08.02 Formulary Cancer Drugs Fund Ranibizumab Lucentis
09.01.04 Formulary Cancer Drugs Fund Romiplostim Nplate
13.05.03 Formulary Cancer Drugs Fund Secukinumab Cosentyx
05.03.03.02 Non Formulary Cancer Drugs Fund Simeprevir Olysio
05.03.03.02 Formulary Cancer Drugs Fund Sofosbuvir Sovaldi
05.03.03.02 Non Formulary Cancer Drugs Fund Telaprevir Incivo
06.06.01 Formulary Cancer Drugs Fund Teriparatide Forsteo
06.05.02 Formulary Cancer Drugs Fund Tolvaptan Samsca
13.05.03 Formulary Cancer Drugs Fund Ustekinumab 
01.05.03 Restricted Use Cancer Drugs Fund Vedolizumab Entyvio
The Pennine Acute Hospitals